Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$36,000.00

Design, development, and validation of assessment methodologies for in vivo and ex vivo study of the aging human brain

EF 2023-24

Résumé
In vivo, signs of pathology can be detected via structural magnetic resonance imaging (MRI). These biomarkers reflect the location and severity of the abnormality and can be used to determine longitudinal aging trajectories. However, while sensitive, MRI is not sufficiently specific to determine the underlying pathology of these biomarkers. Ex vivo identification of the histological substrates of the MRI biomarkers can thus lead to a more refined interpretation of the in vivo findings and help determine their underlying pathology and potential mechanisms. The main challenge in achieving this lies in translating the ex vivo findings to in vivo. The long-term goal of this program is to develop automated techniques to study the human brain using ex vivo MRI and histopathology, and translation of the ex vivo findings to in vivo. This will allow us to investigate the underlying pathologies of age-related brain alterations and quantify these changes across the lifespan. Thus, in the short term, we will develop an automated pipeline that performs: O1. spatial mapping of in vivo MRIs to ex vivo MRIs and histology images; O2. accurate detection of in vivo biomarkers in ex vivo MRIs; and O3. prediction of post-mortem pathology using in vivo and ex vivo MRIs. Data: I am member of various research initiatives collecting in vivo MRI in which participants have consented for brain donation to the Douglas-Bell Canada brain bank. I also have access to the body donor program at the Anatomy Department of the Université du Québec à Trois-Rivières. We collect in vivo medical history and MRI as well as ex vivo MRI and histopathology data of normal aging brains through these programs. We acquire 3T MRIs of the specimens prior to sectioning for histology, and 7T MRIs of the histology blocks prior to staining. O1. Spatial mapping: We will develop an open-source image processing pipeline that takes the raw in vivo and ex vivo MRIs and histology images as inputs and provides pre-processed and co-registered images in a standard space as the output. O2. Ex vivo segmentation: We will extend my previous work from in vivo MRI segmentation to ex vivo MRIs using a combination of image processing, machine learning, and deep learning techniques, validating the results against gold standard manually delineated labels. O3. Pathology prediction: We will develop machine learning models that provide the probability of presence of a specific pathology and its severity based on the multi-sequence MRIs. Impact: This innovative program will lead to development of a novel open access ex vivo dataset accompanied by an open-source ex vivo MRI processing pipeline that researchers in Canada and worldwide can take advantage of. Establishing models that link MRI and histology will improve our MRI detection capability as well as our understanding of the underlying pathologies. This platform is also ideal for training HQP in technical and research skills that are in high demand in Canada.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2023-04038
Name nom
Dadar, Mahsa
Department département
Psychiatry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1507
Committee name en
Computer Science
Committee name fr
Sciences informatiques
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Life sciences research related to human health and disease
Research subject en
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Application title
Design, development, and validation of assessment methodologies for in vivo and ex vivo study of the aging human brain
Keyword
brain histopathology; ex vivo brain MRI; image processing; in vivo brain MRI; machine learning; magnetic resonance imaging (MRI); prediction; registration; segmentation
Application summary
In vivo, signs of pathology can be detected via structural magnetic resonance imaging (MRI). These biomarkers reflect the location and severity of the abnormality and can be used to determine longitudinal aging trajectories. However, while sensitive, MRI is not sufficiently specific to determine the underlying pathology of these biomarkers. Ex vivo identification of the histological substrates of the MRI biomarkers can thus lead to a more refined interpretation of the in vivo findings and help determine their underlying pathology and potential mechanisms. The main challenge in achieving this lies in translating the ex vivo findings to in vivo. The long-term goal of this program is to develop automated techniques to study the human brain using ex vivo MRI and histopathology, and translation of the ex vivo findings to in vivo. This will allow us to investigate the underlying pathologies of age-related brain alterations and quantify these changes across the lifespan. Thus, in the short term, we will develop an automated pipeline that performs: O1. spatial mapping of in vivo MRIs to ex vivo MRIs and histology images; O2. accurate detection of in vivo biomarkers in ex vivo MRIs; and O3. prediction of post-mortem pathology using in vivo and ex vivo MRIs. Data: I am member of various research initiatives collecting in vivo MRI in which participants have consented for brain donation to the Douglas-Bell Canada brain bank. I also have access to the body donor program at the Anatomy Department of the Université du Québec à Trois-Rivières. We collect in vivo medical history and MRI as well as ex vivo MRI and histopathology data of normal aging brains through these programs. We acquire 3T MRIs of the specimens prior to sectioning for histology, and 7T MRIs of the histology blocks prior to staining. O1. Spatial mapping: We will develop an open-source image processing pipeline that takes the raw in vivo and ex vivo MRIs and histology images as inputs and provides pre-processed and co-registered images in a standard space as the output. O2. Ex vivo segmentation: We will extend my previous work from in vivo MRI segmentation to ex vivo MRIs using a combination of image processing, machine learning, and deep learning techniques, validating the results against gold standard manually delineated labels. O3. Pathology prediction: We will develop machine learning models that provide the probability of presence of a specific pathology and its severity based on the multi-sequence MRIs. Impact: This innovative program will lead to development of a novel open access ex vivo dataset accompanied by an open-source ex vivo MRI processing pipeline that researchers in Canada and worldwide can take advantage of. Establishing models that link MRI and histology will improve our MRI detection capability as well as our understanding of the underlying pathologies. This platform is also ideal for training HQP in technical and research skills that are in high demand in Canada.